Drug Pricing Reforms In US Congress: Legacy Systems vs. Cutting-Edge

A House hearing on bipartisan drug pricing reform bills continues the intense focus on the role of pharmacy benefit managers. But it also shows continued interest in finding ways to make payment systems work for cutting edge gene therapies.